Will Long-Acting Glucagon-Like Peptide-1 Analogues Recapitulate Our Agonizing Experience With Cyclic AMP-dependent Positive Inotropic Agents in Heart Failure?

European Journal of Heart Failure - United States
doi 10.1002/ejhf.1047
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Positive inotroPic Agents for Treatment of Acute Heart Failure

The Bulletin of Contemporary Clinical Medicine
2013English

Novel Mono-Lipidated Dimeric Glucagon-Like Peptide-1 Receptor Agonist With Improved Long-Acting and Hypoglycemic Activity

RSC Advances
ChemistryChemical Engineering
2019English

Effect of Glucagon Like Peptide 1| (GLP1) Analogues on Obese Egyptians With and Without Diabetes

The Medical Journal of Cairo University
2019English

Glucagon-Like Peptide 1 and Glucose-Dependent Insulinotropic Polypeptide Analogues as Novel Treatments for Alzheimer’s and Parkinson’s Disease

Cardiovascular Endocrinology
2016English

Glucagon-Like Peptide Analogues for Type 2 Diabetes Mellitus

2007English

Glucagon-Like Peptide-1 and Satiety

Nature
Multidisciplinary
1997English

Positive Allosteric Modulation of the Glucagon-Like Peptide-1 Receptor by Diverse Electrophiles

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2016English

Equine Glucagon-Like Peptide-1 Receptor Physiology

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2018English

A Selective Small Molecule Glucagon-Like Peptide-1 Secretagogue Acting via Depolarization-Coupled Ca2+ Influx

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy